Verition Fund Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Verition Fund Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-94,912	Closed	-$2.37M	–	2510
2025 Q4	$2.37M	Sell	94,912 -19,394	-17%	-$491K	0.01%	1447
2025 Q3	$2.77M	Buy	+114,306	New	+$2.03M	0.01%	1700
2025 Q2	–	Sell	-42,437	Closed	-$610K	–	3662
2025 Q1	$610K	Buy	42,437 +6,242	+17%	+$102K	﹤0.01%	2453
2024 Q4	$606K	Buy	+36,195	New	+$600K	﹤0.01%	2362
2022 Q1	–	Sell	-50,000	Closed	-$563K	–	2768
2021 Q4	$563K	Buy	+50,000	New	+$673K	﹤0.01%	1634

Other funds holding CNTA

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

IVLAV

Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Verition Fund Management's CNTA Position: Q1 2026 in Review

Verition Fund Management sold out of Centessa Pharmaceuticals (CNTA) in Q1 2026, closing a stake of 94,912 shares — an estimated $2.37M sold.

Verition Fund Management first reported a position in CNTA in Q4 2021 and held it in 5 quarters. The position peaked at $2.77M in Q3 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

Verition Fund Management reported no remaining Centessa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Verition Fund Management sold 94,912 Centessa Pharmaceuticals shares in Q1 2026, an estimated $2.37M.
Verition Fund Management first reported a position in Centessa Pharmaceuticals in Q4 2021 and held it in 5 quarters.
Verition Fund Management's Centessa Pharmaceuticals position peaked at $2.77M in Q3 2025.
161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.